Daily Dose: Sore elbow shuts down Santana

Leave a comment

Johan Santana has been scratched from his scheduled Tuesday start with soreness in his left elbow. For now at least the Mets have indicated that they hope the injury is a short-term problem, but several teammates suggested Monday night that Santana may be headed for surgery. He’ll be examined further by doctors Tuesday, at which point the Mets should know whether Santana has a chance to pitch again this year.
Santana has hardly been horrible of late with a 3.94 ERA this month and a 3.22 ERA since the All-Star break, but a closer look at his numbers reveals that something has clearly been off for quite a while. After averaging a career-low 7.9 strikeouts per nine innings last season he produced 11.7 strikeouts per nine innings through the end of May this year, but that dipped to 4.5 in June, 6.5 in July, and now 5.5 in August.
To his credit Santana has been able to maintain an ERA in the low 3.00s the whole time, but a three-month stretch where one of the decade’s greatest strikeout pitchers manages just 60 in 100.2 innings is a definite red flag. As rotation-mate Mike Pelfrey put it: “I don’t think anyone expects good news.” If he does land on the disabled list, Santana would become the 20th Mets player to spend time on the shelf this year.
While the Mets hope for one piece of decent news this season, here are some other notes from around baseball …


* Jake Peavy made his third rehab start Monday at Triple-A, throwing five scoreless innings with three strikeouts and two walks. As recently as a few days ago the White Sox suggested that he’d need several more rehab outings before joining the rotation, but those plans have apparently changed. Jose Contreras has been booted from the rotation following another bad outing Monday and Peavy could be his replacement.
* Scott Baker was 0-4 with a 9.15 ERA and eight homers allowed through four starts, but after turning in another gem Monday night with seven innings of one-run ball he’s now 12-3 with a 3.74 ERA and 109/25 K/BB ratio in 133 innings since. That includes 5-0 with a 2.61 ERA and 43/9 K/BB ratio in eight starts since the All-Star break and he’s been the only Twins starter who hasn’t fallen apart over the past couple months.
AL Quick Hits: Scott Downs came off the disabled list Monday, but Cito Gaston said that he’ll be eased back into closing … Edwin Encarnacion (hamstring) took Downs’ spot on the DL after hitting .186 since being traded to Toronto … Chris Davis will be back in the majors Tuesday after batting .327 in 44 games following his demotion to Triple-A … Brad Penny has been dropped from Boston’s rotation in favor of Junichi Tazawa, at least until Tim Wakefield (calf) returns from the DL … Carl Crawford left Monday’s game with lower back tightness … Daisuke Matsuzaka (shoulder) tossed three scoreless innings in a rehab start Monday at rookie-ball … Justin Morneau was back in the lineup Monday after missing six games with an inner-ear infection … Roy Halladay got knocked around Monday for a second straight start, coughing up eight runs on 12 hits … Joe Saunders’ (shoulder) return from the DL has been moved up to Wednesday after a successful simulated game … Ichiro Suzuki missed Monday’s game with a strained calf, but hopes to be back in the lineup Wednesday.
NL Quick Hits: Tony La Russa said Monday that John Smoltz was tipping his pitches while struggling in Boston, but facing the Padres, Nationals, and Pirates in his first three NL starts will help too … Cliff Lee gave up just a pair of unearned runs in seven innings Monday, improving to 5-0 with a 0.68 ERA and zero homers allowed in five Phillies starts … Aaron Cook (shoulder) may be able to return before the end of the regular season after an MRI exam Monday revealed no structural damage … Pablo Sandoval left Monday’s game with a strained calf … Ryan Howard homered twice off Bobby Parnell and knocked in five runs Monday, passing the 100-RBI mark … Ryan Hanigan landed on the disabled list Monday with post-concussion symptoms from a foul tip off and Chris Dickerson (ankle) joined him on the shelf … Jason Giambi will likely join the Rockies in September after inking a minor-league deal Monday … Jeff Francoeur is day-to-day with a torn thumb ligament suffering trying to make a catch.

The Yankees are paying $86 million for a one-inning reliever

chapman
Leave a comment

OXON HILL, MD — The Yankees signing of Aroldis Chapman late Wednesday night came as something of a surprise. And the money — $86 million — was something of a shock. Yes, we knew that Chapman was going to break the bank and likely set a record as the highest paid relief pitcher in history, but seeing it in black and white like that is still rather jarring.

In the coming days, many people who attempt to analyze and contextualize this signing will do so by pointing to the 2016 playoffs and the unconventional use of relievers by Terry Francona and the Indians and Joe Maddon of the Cubs. They’ll talk about how the paradigm of bullpen use has shifted and how relief pitchers have taken on a new importance in today’s game. Chapman’s astronomical salary, therefore, will be described as somehow more reasonable and somewhat less shocking than it first seems.

Don’t buy that jive for a second.

Yes, Andrew Miller and, to some extent, Chapman himself were used unconventionally in the 2016 playoffs, but not long into the 2017 season we will see that as an exception, not the rule. And not just because Chapman showed himself unable to hold up to that level of use in the playoffs. It will be the excaption because the Yankees have shown no inclination whatsoever to deviate from traditional bullpen usage in the past and there is no reason to expect that they will do so with Chapman in the future.

As you no doubt remember, the Yankees had Chapman, Dellin Betances and Andrew Miller for the first half of 2016. Such an imposing back end of a bullpen has rarely been seen in recent history. All of them, however, were used, more or less, as one-inning-a-piece guys and no real effort was ever made to break any bullpen usage paradigms or to shorten games the way many applauded Terry Francona for doing in the playoffs.

Miller pitched 44 games for the Yankees, totaling 45.1 innings. He pitched more than a single inning on only three occasions. Chapman pitched 31 games for the Yankees, amassing 31.1 innings. He was used for more than one inning only twice. Betances worked in 73 games, totaling 73 innings. On 11 occasions he pitched more than one inning.  It was unconventional for a team to have three relievers that good, but they were not, in any way, used unconventionally. Nor is there any reason to expect Chapman to be used unconventionally in 2017, especially given that Miller is not around and Chapman has shown no real ability to be stretched for multiple innings for a sustained period.

None of which is to say that having Chapman around is a bad thing or that he is any less of a closer than his reputation suggests. It’s merely to say that the Yankees paying Chapman unprecedented money for a closer should not be justified by the alleged new importance of relief pitchers or that changing role for them we heard so much about in the playoffs. Indeed,  I suspect that that changing role applies only to pitcher use in the playoffs. And I do not suspect that this transaction alone pushes the Yankees into serious playoff contention, making that temporary unconventionality something of a moot point in New York for the foreseeable future.

It is almost certain that the Yankees are paying $86 million for the same one-inning closer Aroldis Chapman has been for his entire seven-year career. His contract may or may not prove to be a good one for New York based on how he performs, but don’t let anyone tell you now, in Decemeber 2016, that it’s better than you think because Chapman will somehow transform into a 1970s-style relief ace or something.

Report: Yankees sign Aroldis Chapman to a five-year, $86 million deal

gettyimages-577291896
Getty Images
9 Comments

Update (12:02 AM EST): Rosenthal adds that Chapman’s contract includes an opt-out clause after three seasons, a full no-trade clause for the first three years of the contract, and a limited no-trade clause for the final two years.

*

Ken Rosenthal of FOX Sports reports that the Yankees have signed closer Aroldis Chapman to a five-year, $86 million contract. Mark Melancon recently set the record for a contract earned by a reliever at $62 million over four years. Chapman blew that out of the water and many are surprised he didn’t fetch more.

Chapman, 28, began the 2016 season with the Yankees but he was traded to the Cubs near the end of July in exchange for four prospects. The Cubs, of course, would go on to win the World Series in large part due to Chapman. The lefty finished the regular season with a 1.55 ERA, 36 saves, and a 90/18 K/BB ratio in 58 innings between the two teams.

Chapman was the best reliever on the free agent market and, because he was traded midseason, he didn’t have draft pick compensation attached to him.

The Yankees don’t seem to be deterred by Chapman’s domestic violence issue from last offseason, resulting in a 30-game suspension to begin the 2016 regular season.